New field test allows rapid diagnosis of Chikungunya virus infection

September 29, 2016

CHIKV infection causes symptoms that are similar to Dengue and Zika as well as other viral diseases, including influenza. Accurate diagnosis of CHIKV is important for effective outbreak responses, including patient management and mosquito control. A study published in PLOS Neglected Tropical Diseases reports a rapid accurate test for CHIKV that is performed in a small portable laboratory and can be used anywhere.

Matthias Niedrig, from the Robert-Koch-Institute in Berlin, Germany, and colleagues work on rapid, cheap, and easy diagnostic assays for CHIKV and related viruses. In this study, they developed a reverse transcriptase (RT) recombinase polymerase amplification (RPA) assay for rapid detection of CHIKV in clinical samples. RPA-based detection of small amounts of DNA is an alternative to PCR and based on reactions that can run at constant temperatures rather than needing a thermal cycler. By adding RT, the assay can detect small amounts of RNA, including sequences unique to specific RNA viruses.

Discussing the findings, the researchers highlight that RPA reagents are stable at ambient temperature (25-38°C), meaning they do not need to be refrigerated. In its current form, however, the assay still requires multiple pipetting steps, and the researchers say further simplification and miniaturization is needed to bring the cost down from the current 5 USD per sample 1 USD, which would maximize use in affected countries.

Explore further: Chikungunya test also distinguishes the illness from other mosquito-borne diseases

More information: PLOS Neglected Tropical Diseases, dx.plos.org/10.1371/journal.pntd.0004953

Related Stories

Chikungunya test also distinguishes the illness from other mosquito-borne diseases

October 21, 2015
A detection assay that identifies the presence of viral-specific antibodies in patients with Chikungunya virus (CHIKV) has been developed by A*STAR researchers. The technique can also help differentiate between CHIKV and ...

Novel vaccine strategy produces rapid and long-term protection against Chikungunya virus

March 31, 2016
The Chikungunya virus (CHIKV) is transmitted through mosquitoes and causes fever and joint pain that can sometimes become severe and disabling. Outbreaks of the virus have already occurred in Africa, Asia, and Europe, and ...

New device provides chikungunya test results in an hour

May 12, 2015
Scientists at a U.S. Army research center have modified an assay that tests whether or not a sample of mosquitoes harbors the virus responsible for the disease known as chikungunya (CHIKV), long a problem in the Old World ...

Details of monkey antibodies against chikungunya virus could help to fight the disease in humans

September 24, 2014
Chikungunya fever can cause severe and long-lasting joint pain, with several epidemics affecting multiple continents in the past decade. The illness is caused by chikungunya virus (CHIKV), but there is no effective vaccine ...

Virology: Seeking solutions to viral migration

July 3, 2013
Although seldom fatal, persistent infection by chikungunya virus (CHIKV) afflicts patients with joint pain lasting months or even years. This insect-borne virus has received relatively little scientific attention in the 50 ...

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.